Chromocell Therapeutics Corporation – AMEX:CHRO
Chromocell Therapeutics stock price today
Chromocell Therapeutics stock price monthly change
Chromocell Therapeutics stock price quarterly change
Chromocell Therapeutics key metrics
Market Cap | 3.82M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | N/A |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeChromocell Therapeutics stock price history
Chromocell Therapeutics stock forecast
Chromocell Therapeutics financial statements
| 2020 | 199.93K | -660.58K | -330.4% |
|---|---|---|---|
| 2023 | 0 | -7.38M |
| 2023 | 96391 | 6.54M | 6785.84% |
|---|
| 2022 | -1.56M | 0 | 1.62M |
|---|---|---|---|
| 2023 | -981.03K | 0 | 1.02M |
Chromocell Therapeutics alternative data
| Jun 2024 | 4 |
|---|---|
| Jul 2024 | 4 |
| Dec 2024 | 4 |
Chromocell Therapeutics other data
-
What's the price of Chromocell Therapeutics stock today?
One share of Chromocell Therapeutics stock can currently be purchased for approximately $1.37.
-
When is Chromocell Therapeutics's next earnings date?
Unfortunately, Chromocell Therapeutics's (CHRO) next earnings date is currently unknown.
-
Does Chromocell Therapeutics pay dividends?
No, Chromocell Therapeutics does not pay dividends.
-
How much money does Chromocell Therapeutics make?
Chromocell Therapeutics has a market capitalization of 3.82M.
-
What is Chromocell Therapeutics's stock symbol?
Chromocell Therapeutics Corporation is traded on the AMEX under the ticker symbol "CHRO".
-
What is Chromocell Therapeutics's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Chromocell Therapeutics?
Shares of Chromocell Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Chromocell Therapeutics have?
As Dec 2024, Chromocell Therapeutics employs 4 workers.
-
When Chromocell Therapeutics went public?
Chromocell Therapeutics Corporation is publicly traded company for just a year since IPO on 16 Feb 2024.
-
What is Chromocell Therapeutics's official website?
The official website for Chromocell Therapeutics is chromocell.com.
-
Where are Chromocell Therapeutics's headquarters?
Chromocell Therapeutics is headquartered at 4400 Route 9 South, Freehold, NJ.
-
How can i contact Chromocell Therapeutics?
Chromocell Therapeutics's mailing address is 4400 Route 9 South, Freehold, NJ and company can be reached via phone at +7 325142636.
Chromocell Therapeutics company profile:
Chromocell Therapeutics Corporation
chromocell.comAMEX
4
Biotechnology
Healthcare
Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.
Freehold, NJ 07728
CIK: 0001386026
ISIN: US1711261057
:
